-+ 0.00%
-+ 0.00%
-+ 0.00%

Envoy Medical Secures 3 New Australian Patents For Advanced Cochlear Implant Technologies

Benzinga·07/01/2025 12:10:28
Listen to the news

Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of three new patents, further strengthening its intellectual property portfolio in Australia.

The Australian Patent Office has issued the following three patents to Envoy Medical Corporation:

  • Australian Patent No. 2021391396 on April 24, 2025. The title of the patent is Implantable Cochlear Implant Stimulation Calibration. This patent relates to cochlear implant systems having a testing circuit that determines an amount of current provided by a source element of the system. The source element can be adjusted to calibrate an amount of current provided by the system during stimulation.
  • Australian Patent No. 2021390456, on May 8, 2025. The title of the patent is Combination Hearing Aid and Cochlear Implant System. This patent relates to cochlear implant systems that update operations to compensate for the presence of an external hearing aid to improve simultaneous operation of the cochlear implant system and the external hearing aid and prevent the hearing aid from skewing sounds perceived by a wearer.
  • Australian Patent No. 2022227534, on May 22, 2025. The title of the patent is Recharge System for Implantable Battery. This patent relates to systems and methods for predicting a cumulative thermal dose associated with charging an implanted rechargeable battery and monitoring charging parameters such as temperature to minimize battery charging time while maintaining safe thermal conditions.